about
Pandemic influenza preparedness in Africa is a profound challenge for an already distressed region: analysis of national preparedness plans.The impact of an 8-year mass drug administration programme on prevalence, intensity and co-infections of soil-transmitted helminthiases in BurundiCountrywide Reassessment of Schistosoma mansoni Infection in Burundi Using a Urine-Circulating Cathodic Antigen Rapid Test: Informing the National Control Program.Mass drug administration in Central Equatoria, South Sudan: results and suggestions for future distributions.Potential (18)F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase.Neglected tropical diseases: exploring long term practical approaches to achieve sustainable disease elimination and beyond.Labeled EGFr-TK irreversible inhibitor (ML03): in vitro and in vivo properties, potential as PET biomarker for cancer and feasibility as anticancer drug.Latent class analysis to evaluate performance of point-of-care CCA for low-intensity Schistosoma mansoni infections in Burundi.Capacity gaps in health facilities for case management of intestinal schistosomiasis and soil-transmitted helminthiasis in Burundi.Probucol reduces hepatic cholesterol secretion in hyperlipidemic Yoshida ratsComparison of the hepatic uptake and processing of cholesterol from chylomicrons of different fatty acid composition in the rat in vivoMapping Schistosoma mansoni endemicity in Rwanda: a critical assessment of geographical disparities arising from circulating cathodic antigen versus Kato-Katz diagnosticsGender-related factors affecting health seeking for neglected tropical diseases: findings from a qualitative study in EthiopiaMapping Soil-Transmitted Helminth Parasite Infection in Rwanda: Estimating Endemicity and Identifying At-Risk Populations
P50
Q30229005-1645219A-431A-4CD0-AFC5-FB183CC5D441Q37278516-8E43E7AC-911E-4752-8007-5811A5D4CA76Q37715364-BD152D47-7A4F-498B-96EA-CE4C8DECA507Q38642140-3CDC7037-74FC-4AC2-A3C0-331F78DDD233Q40800760-0D807858-445D-46E6-800D-2C4B99DCCE91Q41673933-71AFC651-889C-4797-8A95-E11330AF59CFQ44124412-2ED302CE-AF61-44C1-94DE-967D893A55EFQ50317536-F823DFF9-3260-4851-B303-666CEA172D9BQ55518648-0796182B-DE6E-481E-966A-1DA7E645CDA5Q71535478-7E99C711-53D9-499C-A4A1-A7A47860A2DCQ71715905-BC0A7AB4-F0F1-45E2-B8D6-1FBB96DB3A48Q90375189-D8505A94-3489-454E-99BD-A8CA3E9F694FQ91917163-D86898B0-F42B-4FCF-9AF9-D97070DF5318Q92814884-CD413E19-7CD4-4C70-B694-51F6B87015ED
P50
description
researcher
@en
wetenschapper
@nl
name
G Ortu
@en
G Ortu
@nl
type
label
G Ortu
@en
G Ortu
@nl
prefLabel
G Ortu
@en
G Ortu
@nl
P106
P31
P496
0000-0001-9234-756X